Carlos Toro

Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection

Berta Rodés, Carlos Toro, Ellen E. Paxinos et al. · AIDS · 2004 · 115 citations

Disease Progression, Immunodeficiencies, Immunology +19

Evolution of genotypic and phenotypic resistance to Enfuvirtide in HIV‐infected patients experiencing prolonged virologic failure

Eva Poveda, Berta Rodés, Jean‐Louis Labernardière et al. · Journal of Medical Virology · 2004 · 75 citations

Seroprevalence of HIV-1, HBV, HTLV-1 and Treponema pallidum among pregnant women in a rural hospital in Southern Ethiopia

José Manuel Ramos, Carlos Toro, Francisco Reyes et al. · Journal of Clinical Virology · 2011 · 56 citations

Clinical Infectious Disease, Global Health, Southern Ethiopia +9

Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor

Eva Poveda, Berta Rodés, Carlos Toro et al. · AIDS · 2002 · 56 citations

Amino Acid, Gp41 Env Region, Human Retrovirus +14

Are Fusion Inhibitors Active against All HIV Variants?

Eva Poveda, Berta Rodés, Carlos Toro et al. · AIDS Research and Human Retroviruses · 2004 · 50 citations

Potential Susceptibility, Medicine, Human Retrovirus +14